Cambrex Corporation (CBM): 33% Downside Risk According to Lakewood Capital Investor Letter
Analysts remain optimistic that Cambrex Corporation (NYSE:CBM) will enjoy revenue and earnings growth next year despite sales pressure on its leading product; Anthony Bozza of Lakewood Capital believes...


